Submission Information

Sections and Organization

Supporting Documentation (facilitates blinded review):

  • Title
  • Authors and Affiliations
  • Corresponding Author
  • Authorship requirements
  • Acknowledgments
  • Previous manuscript submission
  • Conflict of Interest Declarations
  • Cover Letter
  •  Redundant or Duplicate Publication

Main Manuscript Components (for double blind reveiw):

  • Abstract
  • Introduction
  • Methods (or Methods and Materials)
  • Human and Animal Subjects
  • Results
  • Discussion
  • Supporting information captions
  • Funding statement
  • References
  • Supporting Information
  • Figures, Tables and Multimedia
  • Video Abstract


Parts of a Submission

Follow guidance for developing each component below. Many manuscripts are rejected due to formatting issues. For additional resources available to aid authors in improving article quality, please see:

Supporting Documentation File Submission

  1. Title page

Include a full title of up to 200 characters

  1. Author list, names, and affiliations page

Enter all qualifying author names of the manuscript in the following order:

  1. First name (or initials, if used), Middle name (or initial), Last name (surname/family name)
  2. Each author listed must have an affiliation. The affiliation can include department, university, or organizational affiliation. Please include city, state/province (if applicable), and country.
  3. If an author has multiple affiliations, enter them all on this page. In the BHTY submission system, enter only the preferred or primary affiliation. Author affiliations will be listed in the same order they are listed in the submission file. Author names will be published exactly as they appear in the manuscript. BHTY will not be responsible for incorrectly submitted information.
  4. Author emails and ORCID ID are required if available. Should your manuscript be accepted, ORCID IDs will be included on the published article.
  1. Corresponding author

The submitting author will be designated as the “corresponding author” in the submission system. Corresponding authors act as BHTY's primary contact and the only author able to view or change the manuscript while it is under editorial review.

The corresponding author role may be transferred to another coauthor with the written approval of all authors. Transferring the corresponding author role also transfers access to the manuscript submission. The corresponding author will be listed as such upon publication.

      3a. Corresponding author contact details

Please provide full contact details for the corresponding author including email, mailing address, and telephone number(s).

  1. Authorship requirements

Manuscripts are exclusively submitted to BHTY, with the understanding they have not been published elsewhere, in any form, and will not be submitted elsewhere, unless declined by BHTY.

BHTY endeavors to follow, the ICMJE recommendations for scholarly work in medical journals, as it aspires to adhere to the highest standards of scholarly publication practices. Details may be obtained here. 

Below you will find the "Role of Authors and Contributors" as outlined by ICMJE. Should you wish for a more detailed explanation, please click here. All authors must meet all four criteria below.

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributors who do not meet the criteria above, can be listed in the Acknowledgments section of the manuscript. See the International Committee of Medical Journal Editors (ICMJE) guidelines for "Non-Author Contributors" here." Obtaining funding, collecting of data, or overall supervision of a research group, does not qualify authorship.

BHTY expects all authors to review, discuss, and agree to their individual contributions and roles.

  1. Acknowledgments

Those who contributed to the work but do not meet authorship criteria should be listed in Acknowledgments with a description of their role. Authors are responsible for ensuring those named in Acknowledgments agree to be included. Please note that the Acknowledgement section should be included in the title page and uploaded separately to ensure a double blind review.

  1. Previous manuscript submission

If a manuscripts was submitted to another journal and declined, the author should disclose why, and what attempts have been made to revise the manuscript, for resubmission. Authors are responsible for all statements made in the article and references cited.

  1. Conflict of Interests page

Authors are responsible for disclosing financial support from commercial entities or other non financial conflicts of interest that might bias the interpretation of results. If no competing interests exist, please state "The authors declare no potential conflicts of interest".  The conflict of interest page should uploaded as a supplementary file, and not part of the main manuscript.

Competing interests include any financial interests, direct or indirect, that might raise questions regarding bias in the your work, conclusions, implications or perspectives stated – including relevant commercial or other sources of funding for each individual author(s).

It is the role of the corresponding author to ensure this is adhered to.

  1. Cover Letter page

The cover letter should address the following questions:

  1. Why is this manuscript suitable for publication in BHTY?
  2. Why will your study, initiative, or opinion inspire researchers or clinicians, and how will it improve patient care or public health, or drive the understanding and impact of the sector forward?
  3. All cover letters should contain these sentences:
    1. We confirm this manuscript has notbeen published elsewhere, no parts are plagiarized in any form or degree, and is not under consideration by another journal.
    2. All authors have approved the manuscript, and agree with its submission to Blockchain in Healthcare Today
  2. Redundant or Duplicate Publication

According to COPE, a redundant publication is a “work, or sections of that work, that is published more than once.”  If redundant or duplicate publication is attempted or occurs without notification to BHTY, the journal will follow the editorial action contained in the COPE Flowchart for Redundant Publication.

Authors should alert the editor if the work includes subject matter about which a previous paper has been published. Referred work should be referenced in the new paper. Copies of materials, including papers in press, should be submitted with your manuscript submission to assist the editor in determining how to handle the issue.


Main Manuscript File Submission

  1. Title page

Include a full title of up to 200 characters without author names or titles, to ensure double blind peer review.

  1. Abstract

Your original research manuscript submission MUST contain an abstract. The Abstract comes after the title page in the manuscript file. The journal requires structured abstracts. The abstract should be 250-400 words. Please see CONSORT or PRISMA style abstract formats to determine which to use for your paper.

The abstract must be structured with headings (Objective, Design, Setting, Participants, Interventions, Main outcome measures, Results, Conclusions). For meta-analyses headings are typically: Objective, Design, Results, and Conclusion.

Provide trial registration number(s) for clinical randomized controlled trials.

  1. Introduction

The Introduction should present a broad context for the manuscript. Think of readers who are not experts that may read your article. Include a brief review of key literature. If there are relevant issues pro and con in the field, mention them so a non-expert can understand. The Introduction should end with a statement of the overall purpose of the experiment(s) and a commentary on whether it was achieved.

  1. Background

This section should clearly describe your study rationale. It should end with a statement of the specific study hypothesis and/or study objectives.

  1. Methods and Findings
  • Describe study participants or what was studied (e.g., hospital readmission, be specific). Describe the study design, intervention, methods used, outcome measure(s), and any follow up
  • Include how many participants completed out of those enrolled, and response rates where applicable
  • Describe how results were analyzed, i.e., which specific statistical tests were used
  • Describe the main outcomes and quantify results using % confidence intervals if possible. Describe adverse events.
  • Describe any limitations of the study

Methods should provide enough detail for reproduction of the findings. Protocols for new methods should be included. Well-established methodological procedures may simply be referenced. A full description of the methods should be included within the manuscript.

Methods should also include a section with descriptions of any statistical methods used. The description should conform to the ICMJE Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication, published in the J Pharmacol Pharmacother. 2010 Jan-Jun; 1(1): 42–58., and available at the following link here. It reads as follows:

Submit detailed protocols for newer or less established methods. Well-established protocols may simply be referenced. Protocol documents for clinical trials, observational studies, and other non-laboratory investigations may be uploaded as supporting information.

We recommend you explore laboratory protocols in, where protocols can be assigned their own persistent digital object identifiers (DOIs).

To include a link to a protocol in your article:

  • Describe your step-by-step protocol on
  • Select Get DOI to issue your protocol a persistent digital object identifier (DOI) 
  • Include the DOI link in the Methods section of your manuscript using the following format provided by

This allows editors and reviewers to consult your protocol when evaluating the manuscript. Any referenced protocol(s) will automatically be made public when your article is published.

  1.  Conclusions

Provide an interpretation of results with recommendations for future research.

For clinical trials, provide the trial identification number(s) and name(s) (e.g., trial registration number, protocol number or acronym).

6a. Human and Animal Subjects 

BHTY endorses appropriate reporting guidelines when writing a health research manuscript. The most commonly required reporting guidelines may be found on the EQUATOR Network , which also gives general information on how to choose the correct guideline and why guidelines are important.

BHTY follows the guidelines of the International Committee of Medical Journal Editors.

When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), and/or in accordance with the Helsinki Declaration (revised in 2013). Authors must explain rationale for their approach and demonstrate the institutional review body explicitly approved any doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment as to whether the conduct of the research was appropriate. Authors must remember to add the trial registration number to the end of the abstract.

Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects, observing privacy rights of human subjects. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent requires an identifiable patient is shown the manuscript to be published. Informed consent should be obtained if there is any doubt that anonymity can be maintained. If identifying characteristics are de-identified, authors should provide assurance that such changes do not distort scientific meaning.

For manuscripts reporting experiments on animals, the corresponding author must confirm that all experiments were performed in accordance with relevant guidelines and regulations. The manuscript must include a statement identifying the institutional and/or licensing committee approving the experiments, including any relevant details.

  1. Results

The Results section should include all primary and secondary outcome measures analyzed. The section may be divided into subsections, each with a concise subheading. Tables and figures central to the study should be included in the main paper. The Results section should be written in past tense.

For smaller data sets and certain data types, authors may provide their data within their manuscript or in Supporting Information files accompanying the manuscript. Authors should attempt to maximize the accessibility and reusability of data by selecting file formats where data can be easily and efficiently extracted. An example is spreadsheets or flat files in lieu of PDFs for tabulated data.

Ensure the methodology has been accurately described for statistical analysis. Include details and access to original data to verify results. Provide confidence levels, and define terms and symbols.  Include software used. In comparative studies, power calculations are usually required. In research manuscripts, requiring complex statistics, the advice of an expert statistician should be sought at the design/implementation stage of the study. It is appropriate to include statisticians as co-authors. Should you have further questions, please contact the managing editor.

BHTY strongly urges authors to make all data underlying the findings described in their manuscript fully available without restriction. Authors can include relevant software code and data in the peer review process by uploading it to BHTY’s Code Ocean computational reproducibility workflow; and strengthen the validity, attribution, and trust-based reputation of their work with BHTY’s service option, a purpose built blockchain-enabled platform for academic and scientific research and development.

  1. Discussion

The Discussion should be tightly argued. Start with a summary of the main findings. Include paragraphs on the generalizability, clinical relevance, strengths, and limitations of your study. You may also want to add the following:

  • How conclusions affect existing knowledge in the field?
  • How might future research build on your observations and what path forward should we seek as a result?
  1. Funding Statement

This section should describe sources of funding that have supported the work. Please include relevant grant numbers and the URL of any funder's web site. Please also include this sentence: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Otherwise, describe the role of your sponsors or funders, and amend the aforementioned sentence as needed.

  1. References

All available works can be cited in the reference list and must be formatted in the Vancouver style. MANUSCRIPTS FAILING TO FOLLOW THIS STYLE WILL BE RETURNED TO THE AUTHOR(S) FOR CORRECTION. References are to be provided in the Vancouver style for original research, editorials/perspective articles and BLOG submissions. Acceptable sources include:

  • Published or accepted manuscripts
  • Manuscripts on preprint servers, if the manuscript is submitted to a journal and also publicly available as a preprint
  • Do not cite the following sources in the reference list:
    •  Unavailable and unpublished work, submitted but not yet accepted manuscripts.  Include this data as supplementary material or deposit the data in a publicly available database.
  • References are listed at the end of the manuscript and numbered in the order that they appear in the text.
  • Do not include citations in abstracts or author summaries. 
  • Make sure the parts of the manuscript are in the correct order before ordering the citations.

Formatting references

  •  BHTY will make every effort to link references electronically to the papers they cite, therefore, proper formatting of the references is crucial. 
  • BHTY uses the reference style outlined by the International Committee of Medical Journal Editors (ICMJE), also referred to as the Vancouver styleDOI numbers should be included where available.
  • In-text citations
    • We suggest you cite supporting information in the manuscript text, but this is not a requirement. If you cite supporting information in the text, citations do not need to be in numerical order.

Two examples of Vancouver style for the most commonly cited references are shown below. Note: bold type shows what must be added to the citation if available. Do not use bold type in your reference list.

If you have the DOI:

Oliver M, Teruel MA, Molina JP, Romero-Ayuso D, González P. Ambient intelligence environment for home cognitive telerehabilitation. Sensors (Basel) 2018;18:3671-4. DOI: 

If you have the URL:

Xixi L, Rai A, Ganapathy K. Designing cost-effective telemedicine camps for underprivileged individuals in less developed countries: a decomposed affordance-effectivity framework.  J Assoc Inf Syst 2020;25:9-12. Available from: [cited 9 July 2021].

  1. Supporting Information

Authors can submit essential supporting files and multimedia files along with their manuscripts. All supporting information will be subject to peer review. All file types can be submitted. Supporting information files are published exactly as provided, and are not copyedited.

Supporting information captions

List supporting information captions at the end of the manuscript file and not in a separate file. The file number and name are required in a caption. We recommend including a one-line title. You can include a legend, but it is not required.

  1. Figures, Tables and Multimedia

Figure preparation files and integrity

BHTY acknowledges authors may manipulate images for purposes of clarity. Manipulation for purposes of deception or fraud is ethical misconduct and will be dealt with accordingly. Images may not be enhanced, obscured, moved, removed, or inserted. Please follow the CSE's guidelines for more information:

Figure citations

  • Cite figures consecutively in the order they have been cited in the text.  If you are using a figure that has been published previously, you must obtain written approval to reproduce it.
  • Figure captions must be inserted in the text of the manuscript immediately following the paragraph in which the figure was first cited (read order). Do not include captions as part of the figure files themselves. Please be sure all numbers, letters, and symbols that appear with figures are large enough to read when they are reduced for publication.
  • Legends for illustrations should be on a separate page of the manuscript
  • Upon revision, each figure must be prepared and submitted to the submission system as an individual file


Cite tables in ascending numeric order upon first appearance in the manuscript file.

Place each table in your manuscript file directly after the paragraph in which it is first cited (read order). Do not submit your tables in separate files.

Tables require a label (e.g., “Table 1”) and brief descriptive title to be placed above the table. Place legends, footnotes, and other text below the table. 

Multimedia and 3D Models

BHTY publishes multimedia and 3D models embedded in the HTML and PDF versions of articles. These will be displayed in line with article text, as are with figures.

Multimedia and 3D models are accepted when needed to show findings that 1) are critical to argue article conclusions and 2) can't be satisfactorily presented in text, table, or figure. The editors will determine if this medium is used appropriately.

  1. Text Citation

Multimedia and 3D models must be numbered independently of figures and tables, and cited at the relevant point in the manuscript text, e.g., “Movie 1”, and “Model 1”.


A title should be part of the legend and not incorporated in the multimedia or 3D model itself.


A legend must be included in the manuscript document after the reference list and not included in the video or 3D model itself. Legends should include sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information. If videos are not in real time and the time is not displayed in the video, the period represented must be stated in the legend. Rather than stating “See text,” legends should be more specific; for example, “See Results”.

Size and Format

Video and 3D models should be sized to convey essential scientific information. 3D models must be in U3D format. 

Video file size limit is 25 MB. If the video file is larger, please supply it via WeTransfer or Dropbox. Upon publication of the article, large video files can be placed on a separate server or repository (Figshare) or similar, whereby a link to the video file will be included in the article abstract.

Please be sure to optimize videos for PC, tablet, and smartphone viewing.

For each video, please submit a preview image, or poster frame, that best illustrates the main focus.

Should you have additional questions as to Figures, Tables, and Multimedia, please contact the managing editor or publisher.

  1. Video Abstract

BHTY accepts video submissions to compliment an author's written work. Videos can demonstrate simulations, experimental demos, or "interviews" with authors/researchers. Authors should submit a jpeg representing the video and/or transcript of audio. Video format may be MP4. Length: 5-7 minutes maximum.

Should you have additional questions as to Figures, Tables, and Multimedia, please contact the managing editor or publisher.